Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,055 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $767.99 | 9 | $0 (2023) |
| AbbVie, Inc. | $640.98 | 9 | $0 (2019) |
| Lilly USA, LLC | $571.30 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $390.74 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $262.44 | 3 | $0 (2019) |
| Dexcom, Inc. | $215.52 | 2 | $0 (2019) |
| Amgen Inc. | $135.81 | 2 | $0 (2019) |
| Abbott Laboratories | $28.07 | 2 | $0 (2019) |
| Ascensia Diabetes Care US Inc. | $21.96 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $20.38 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248.72 | 2 | Lilly USA, LLC ($248.72) |
| 2023 | $246.25 | 2 | Lilly USA, LLC ($124.37) |
| 2022 | $57.38 | 1 | Novo Nordisk Inc ($57.38) |
| 2021 | $233.61 | 2 | Novo Nordisk Inc ($233.61) |
| 2020 | $122.12 | 3 | Lilly USA, LLC ($122.12) |
| 2019 | $1,253 | 13 | AbbVie, Inc. ($307.70) |
| 2018 | $381.74 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($160.08) |
| 2017 | $512.51 | 14 | AbbVie, Inc. ($233.83) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/31/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $124.45 | General |
| Category: Obesity | ||||||
| 02/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.27 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.88 | General |
| 05/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.37 | General |
| Category: Diabetes | ||||||
| 03/23/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $57.38 | General |
| Category: Diabetes | ||||||
| 12/07/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 11/04/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $108.61 | General |
| Category: Diabetes | ||||||
| 03/03/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $96.15 | General |
| 03/03/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 03/03/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $9.62 | General |
| 10/23/2019 | Dexcom, Inc. | DEXCOM CGM (Device) | Food and Beverage | In-kind items and services | $123.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/08/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $100.19 | General |
| Category: Endocrinology | ||||||
| 09/26/2019 | Dexcom, Inc. | DEXCOM CGM (Device) | Food and Beverage | In-kind items and services | $92.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/05/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $82.51 | General |
| Category: Diabetes | ||||||
| 07/25/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $114.02 | General |
| Category: Bone Health | ||||||
| 06/27/2019 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes Care | ||||||
| 06/18/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $115.00 | General |
| 06/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $108.75 | General |
| Category: Diabetes | ||||||
| 04/23/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $92.51 | General |
| 04/11/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $76.09 | General |
| Category: Neuroscience | ||||||
| 04/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $122.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.60 | General |
| 02/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $88.70 | General |
| Category: DIABETES | ||||||
| 08/02/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $122.21 | General |
| Category: Diabetes | ||||||
| 07/31/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $88.19 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,887 | 2,689 | $444,252 | $216,227 |
| 2022 | 20 | 1,932 | 2,759 | $461,561 | $226,416 |
| 2021 | 23 | 1,982 | 3,066 | $541,247 | $254,479 |
| 2020 | 19 | 1,822 | 2,712 | $473,129 | $201,443 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 389 | 714 | $138,516 | $63,894 | 46.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 196 | 313 | $83,884 | $42,308 | 50.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 309 | 309 | $83,430 | $42,172 | 50.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 80 | 80 | $28,480 | $22,525 | 79.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 115 | 117 | $12,870 | $8,379 | 65.1% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 18 | 51 | $16,575 | $7,022 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 96 | $11,808 | $5,743 | 48.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 120 | 122 | $4,636 | $3,910 | 84.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $6,138 | $3,145 | 51.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $4,930 | $2,976 | 60.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,641 | $2,789 | 28.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 80 | 80 | $3,040 | $2,564 | 84.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 214 | 270 | $9,450 | $2,268 | 24.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 41 | 47 | $7,755 | $2,073 | 26.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 18 | 193 | $6,948 | $1,660 | 23.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 96 | 160 | $9,280 | $1,523 | 16.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 14 | 22 | $2,838 | $704.20 | 24.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 38 | $3,648 | $433.30 | 11.9% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 11 | 11 | $385.00 | $138.05 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 398 | 774 | $150,156 | $71,378 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 224 | 332 | $88,976 | $45,887 | 51.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 282 | 282 | $76,140 | $39,240 | 51.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 78 | 78 | $27,865 | $21,716 | 77.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 117 | 117 | $12,870 | $8,006 | 62.2% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 17 | 39 | $19,305 | $6,004 | 31.1% |
About Dr. Susan Ignatius, MD
Dr. Susan Ignatius, MD is a Internal Medicine healthcare provider based in Carol Stream, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649374935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Ignatius, MD has received a total of $3,055 in payments from pharmaceutical and medical device companies, with $248.72 received in 2024. These payments were reported across 41 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($3,055).
As a Medicare-enrolled provider, Ignatius has provided services to 7,623 Medicare beneficiaries, totaling 11,226 services with total Medicare billing of $898,565. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Carol Stream, IL
- Active Since 09/08/2006
- Last Updated 10/23/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649374935
Products in Payments
- Synthroid (Drug) $416.14
- Ozempic (Drug) $313.47
- JARDIANCE (Drug) $269.14
- ENTRESTO (Drug) $262.44
- MOUNJARO (Drug) $248.64
- RYBELSUS (Drug) $233.61
- DEXCOM CGM (Device) $215.52
- ZEPBOUND (Drug) $124.45
- EVENITY (Biological) $114.02
- EMGALITY (Drug) $76.09
- Rybelsus (Drug) $57.38
- Xultophy 100/3.6 (Drug) $23.97
- CONTOUR NEXT ONE Meter (Device) $21.96
- Corlanor (Drug) $21.79
- SOLIQUA (Drug) $20.38
- Androgel (Drug) $17.33
- FreeStyle Libre (Device) $15.09
- CardioMEMS HF System (Device) $12.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Carol Stream
Nausheen Hasan, M.d, M.D
Internal Medicine — Payments: $10,761
Angelo Miele, Md, MD
Internal Medicine — Payments: $1,878
Lawrence Schouten, Md, MD
Internal Medicine — Payments: $1,441
Mark Bednard, Do, DO
Internal Medicine — Payments: $1,380
Asad Rafiq, Md, MD
Internal Medicine — Payments: $1,271
Evelyn Diaz-Jimenez, M.d, M.D
Internal Medicine — Payments: $437.60